BioVie Inc. (BIVI) Financials
BIVI Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| March 31, 2026 | 17.5 million | 1.9 million |
| Dec. 31, 2025 | 22.5 million | 3.2 million |
| Sept. 30, 2025 | 26.8 million | 1.9 million |
| June 30, 2025 | 21.6 million | 2.6 million |
BIVI Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| March 31, 2026 | -7.4 million | 51491 |
| Dec. 31, 2025 | -4.4 million | 486728 |
| Sept. 30, 2025 | -3.0 million | 270559 |
| June 30, 2025 | -5.6 million | 683181 |
BIVI Net Income
No data available :(
BIVI Cash and Debt
Graph available only for paid members. Upgrade to see it.
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| March 31, 2026 | 13.1 million | 213319 | - |
| Dec. 31, 2025 | 20.5 million | - | 314915 |
| Sept. 30, 2025 | 25.0 million | - | 332730 |
| June 30, 2025 | 17.5 million | - | 349894 |
BIVI Shares Outstanding
BIVI Expenses
Graph available only for paid members. Upgrade to see it.
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| March 31, 2026 | - | 3.2 million | 2.2 million | - |
| Dec. 31, 2025 | - | 4.3 million | 1.9 million | - |
| Sept. 30, 2025 | - | 2.9 million | 2.3 million | - |
| June 30, 2025 | - | 1.2 million | 2.4 million | - |
BIVI Cost of Revenue
Graph available only for paid members. Upgrade to see it.
| Date | Revenue | Cost of Revenue |
|---|---|---|
| March 31, 2026 | - | 57344 |
| Dec. 31, 2025 | - | 57344 |
| Sept. 30, 2025 | - | 57344 |
| June 30, 2025 | - | 57344 |
BIVI
Price: $1.76
52 week price:
Earnings Per Share: -3.79 USD
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 123600
Market Capitalization: 12.6 million